SVB’s failure was contained. Its effects on biotech could still linger.
Bio Pharma Dive
MARCH 14, 2023
“A generation of founders is now scarred,” one biotech CEO said, as small drugmakers grapple with the longer-lasting effects of SVB’s stunning collapse
Let's personalize your content